To see whether methylprednisolone would affect the pulmonary vascular response to endotoxemia, we studied responses to endotoxemia in the presence and absence of methylprednisolone in the same chronically instrumented, unanesthetized sheep. Infusion of Escherichia coli endotoxin (0.70-1.33 µg/kg) caused an initial period of marked pulmonary hypertension followed several hours later by a long period of increased vascular permeability when pulmonary vascular pressures were near base line (base-line pulmonary artery pressure (PPa) = 21±1 cm H 2 O SE, left atrial pressure (Pla) = 1±3; experimental PPa = 20±3, Pla = 3±4; P = NS), lung lymph flow (˙Qlym) was high (base-line ˙Qlym = 7.2±0.2 ml/h; experimental ˙Qlym = 23.2±1.0; P < 0.05) and lymph/plasma protein concentration (L/P) was high (base-line L/P = 0.65±0.04; experimental L/P = 0.79±0.05; P < 0.05). When methylprednisolone (1.0 g + 0.5 g/h i.v.) was begun 30 min before the same dose of endotoxin was infused, the initial pulmonary hypertension was less and the late phase increase in lung vascular permeability was prevented (experimental PPa = 24±1, Pla = 1±1, Qlym = 10.0±0.4; L/P = 0.56±0.03). ˙Qlym and L/P were significantly (P < 0.05) lower than with endotoxin alone. Methylprednisolone began during the initial pulmonary hypertensive response to endotoxin also prevented the late phase increase in lung vascular permeability, but the drug had no effect once vascular permeability […] was begtuni 30 min before the same dose of endotoxin was infused, the initial ptilmonary hypertension was less and the late phase increase in lutng vascutlar permeability was prevented (experimental PPa = 24± 1, Pla = 1± 1, Olym = 10.0 ± 0.4; L/P = 0.56 ± 0.03). Olym and L/P were significantly (P < 0.05) lower than with endotoxin alone. Methylprednisolone began duiring the initial putlmonary hypertensive response to endotoxin also prevented the late phase increase inl lutiig vasecular permeability, but the druLg had no effect once vascutlar permeability was increased. We conclude that large doses of methylprednisolone given before or sooIn after endotoxemia prevent the increase in luing vasctular permeability that endotoxin cauises, but do not reverse the abnormality once it occurs.
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INTRODUCTION
There are several theoretical reasons to expect corticosteroids to moderate the pulmonary vascular response to endotoxemia (1, 2) , but a concensus about steroid effects has not emerged from available experimental and clinical data. In chronically instrumented unanesthetized sheep, we have reported a highly reproducible lung vascular response to infusing Escherichia coli endotoxin (3) . There is an initial period of marked pulmonary hypertension and a late, steady-state phase of increased lung vascular permeability. Because the preparation is well-suited to the study of drug effects on the pulmonary vascular reaction to endotoxin and because increased lung vascular permeability appears to cause the pulmonary complications of gram negative sepsis in humans, we studied the effects of large doses of methylprednisolone on the endotoxin reaction in sheep.
We found that methylprednisolone given either prior to endotoxemia or during the initial period of pulmonary hypertension after endotoxemia, largely prevented the late phase increase in lung vascular permeability. However, methylprednisolone did not reverse the increase in permeability once it had occurred.
METHODS

Experimental preparation
We have published several descriptions of how we prepare sheep so that lung lymph can be collected and pressures measured (3) (4) (5) (6) . Through three thoracotomies we put catheters into the left atrium, pulmonary artery and the efferent duct from the caudal mediastinal lymph node. We ligated the tail of that node at the lower margin of the inferior pulmonary ligaments to eliminate systemic lymph (6) and put catheters through neck vessels into the superior vena cava and thoracic aorta. Sheep recovered from surgery and had a stable flow of blood free lymph by 3-5 d after surgery; then we made experiments. In sheep prepared this way, lymph flow in-creases when left atrial pressure is increased but not when right atrial pressure is increased by partial obstruction of the main pulmonary artery (6) , supporting the assumption that the lymph comes mostly from the pulmonary circulation.
Experimental protocols
General. Throughout every experiment, sheep stood in a cage, unanesthetized, while we continuously recorded pulmonary arterial, left atrial and aortic pressures using strain gauges (Micron Instruments, Inc., Los Angeles, Calif.) and an electronic recorder (Hewlett-Packard Co., Palo Alto, Calif.). The zero reference for pressures was the level of the left atrium noted at surgery. We measured lung lymph flow by recording the amount accumulated in a graduated centrifuge tube each 15 min. We collected aortic blood each hour and pooled lymph each half hour and measured their protein concentrations. None of the animals had received endotoxin prior to these studies. We measured Po2, Pco2, and pH in anaerobically collected arterial blood samples using an Instrumentation Laboratory blood gas analyzer (model 513, Instrumentation Laboratory, Inc., Lexington, Mass. The other experiment in each pair was identical except that 30 min before infusing endotoxin, we injected 1 g of methylprednisolone into the superior vena cava, then infused 0.5 g/h methylprednisolone i.v. for 4 h. In each pair of experiments, exactly the same dose and infusion rate of endotoxin was given.
Methylprednisolone given durifig the initial endotoxin response (phase I). In each of four sheep (different animals from those used above) we did two experiments in random order: (a) endotoxin alone exactly as described above; (b) the same dose of endotoxin with an intravenous infusion of methylprednisolone (0.5 g/h for 3 h) begun when the pulmonary artery pressure response to endotoxin was maximal (-30 min). In two animals, steroids were given in the first experiment and in the other two steroids were given in the second experiment. At least 48 h elapsed between studies. We continued all observations until at least 2 h of stable lymph flow and pressures were recorded.
Methylprednisolone given during the increased permeability response to endotoxin (phase II). Three times in three sheep we gave endotoxin alone exactly as above. When the second (high permeability) phase was well established (usually 3-4 h after endotoxin), we infused 1.0 g methylprednisolone (-30 mg methylprednisolone/kg body wt) over 30 min i.v. and continued to measure all parameters for 2-4 h.
Protein measurements
We measured total protein concentrations in lymph and blood plasma by a modified biuret method (7) with an automated system (AutoAnalyzer, Technicon Instruments, Tarrytown, N. Y.); duplicate samples differed <5%.
We separated proteins in blood plasma and lymph samples from steady-state base-line and experimental periods by polyacrylamide gradient gel electrophoresis. The methods are described several times in the literature (5, 6). Using 4-30% polyacrylamide gradient gels, we consistently identified eight protein fractions in plasma and lymph. To estimate the effective molecular radius of each fraction, we calibrated the gels with five proteins with known free diffusion coefficients. From a standard curve of migration distance plotted against Einstein-Stokes radius for the five known proteins we estimated the radius of the eight plasma and lymph fractions.
Statistics
We tested the significance of differences between steadystate base-line and experimental observations using a paired t test (8) . We also calculated means and standard errors for the steady-state data.
RESULTS
Methylprednisolone control studies. A typical experiment where methylprednisolone alone was infused is shown in Fig. 1 and data from four similar studies are summarized in Table I . Methylprednisolone had no significant effect on either pulmonary vascular pressures or lung lymph flow. There was a tendency for lymph protein concentration and lymph/ plasma concentration to decrease slightly, but the changes were not significant.
Methylprednisolone given before endotoxin. (10) . Endotoxin, in striking contrast to left atrial that reported earlier (3) and the reaction was pressure elevation, caused a very large increase in ianimals given steroids plus endotoxin in a lung lymph flow with an increase in lymph/plasma experiment to that in animals given endotoxin protein concentration. This relationship means that their first experiment. There was an initial lung vascular permeability to proteins was increased. marked pulmonary hypertension, increasing Methylprednisolone eliminated the rise in lymph/ )h flow, and decreasing lymph/plasma protein plasma protein concentration and almost eliminated Ltion (phase I), followed in several hours by the increase in lymph flow. ;tate period where pulmonary vascular pres- Fig. 4 shows steady-state lung lymph clearance of e stable, lung lymph flow was very high and eight plasma protein fractions as a function of protein isma protein concentration was higher than molecuilar radius during the base-line period and (phase II). We define this late period of high during the endotoxin response in the presence and otein-rich lymph as the steady-state period of absence of methylprednisolone. Lymph clearance ofall lung vascular permeability (3, 4, 9) ; all proteins increased dramatically during the increased returned to base line by 24-36 h after endo-vascular permeability phase of the endotoxin response. usion. When an infusion of methylpred-In the presence of methylprednisolone, lymph clearwas begun before infusing endotoxin, ani-ance of all proteins was similiar to base line during not develop clinical signs of sepsis (chills, the late-phase response to endotoxin. ss) and the initial response to endotoxin was
The beneficial effects of methylprednisolone started Fig. 2 ). § Data are averaged over 11/2-2 h steady-state period occurring 3-5 h after infusing endotoxin in each experiment (see Fig. 2 ). The same time periods after endotoxin were used in pairs of studies with and without steroids.
"Significantly different from endotoxin alone, P < 0.05. Methylprednisolone given during the initial endotoxin response (phase I). Table III summarizes data from four pairs of experiments like the one illustrated in Fig. 5 . On average, pulmonary artery pressures and lung lymph flows reached similar values in the first phase of the endotoxin response, but methylprednisolone begun during that period substantially reduced the late-phase lymph response. During the steady-state response to endotoxin alone, lung lymph flow was greater than three times base line and lymph/plasma protein concentration was higher than base line. During that same period in the presence of methylprednisolone, lymph flow was 1.3 times base line and lymph/plasma protein concentration was similar to base line.
Methylprednisolone given during the increased permeability response to endotoxin (phase II). Fig. 6 is typical of three experiments where methylprednisolone was infused during the steady state increased permeability response to endotoxemia. Although there was a tendency for pulmonary arterial pressure to decrease slightly after infusing the drug, there were no consistent effects on either lung lymph flow or lymph/plasma protein concentration. Fig. 5 ). § Data are averaged over 11/2 -2 h steady-state period occurring 3-5 h after infusing endotoxin in each experiment (see Fig. 5 ).
Steroid Prevention of Endotoxin Pulmonary Edema
The same time periods after endotoxin were used in pairs of studies with and without steroids. "Significantly different from endotoxin alone, P < 0. (Fig. 4) .
In our experiments, high doses of methylprednisolone (in the range suggested for use in humans with septic shock [13] ) given either before endotoxin or during the initial reaction to endotoxin largely prevented the late-phase increase in lung vascular permeability. The evidence for this is that, in the presence of methylprednisolone, lung lymph flow was near base line during the late phase of the endotoxin re-action and lymph/plasma protein concentration was not increased.
The steady-state phase of increased permeability after endotoxin allowed us to test the ability of methylprednisolone to reverse the abnormality. As illustrated in Fig. 6 , methylprednisolone had no effect once permeability was increased.
At least under some circumstances, corticosteroids appear to inhibit endogenous production of arachidonate products prostaglandins, thromboxanes, and products of lipoxygenase apparently by preventing release of arachidonate from membrane phospholipids (1) . Endotoxin infusion causes an increase in prostaglandins in blood (14) and lung lymph (15) . Inhibition of arachidonate cyclooxygenase (which blocks prostaglandin and thromboxane synthesis) prevents the pulmonary hypertensive response to endotoxemia in calves (14) and sheep (16) . Inhibiting prostaglandin synthesis does not prevent the late-phase increase in lung vascular permeability after endotoxemia in sheep, in fact, it appears to exaggerate the increase in permeability (16) .This difference between the effects of steroids and nonsteroidal antiinflammatory drugs on the endotoxin response indicates that the steroid effect is not due only to inhibition of prostaglandin and thromboxane synthesis.
Corticosteroids could affect the endotoxin reaction indirectly by preventing fever, systemic hemodynamic changes, and other systemic responses to endotoxemia. Our data do not bear directly on the mechanism of the steroid effect, but the ability of high concentrations of corticosteroids to inhibit increased production of lipoxygenase products of arachidonate (1, 17, 18) and to inhibit granulocyte aggregation (2, 19) merit attention. Our earlier studies suggest an important role for granulocytes in the pulmonary vascular response to endotoxemia (20) , and a recent report indicates that SRS-A (a metabolite of arachidonate via lipoxygenase [211) increases permeability in systemic microvessels (22) .
Although extrapolating our data to the more complex clinical situation of gram negative sepsis is difficult, our findings that methylprednisolone given before or very early after endotoxemia prevents increased lung vascular permeability, but that, given late in the reaction, methylprednisolone has no effect, may be relevant to the controversy surrounding use of corticosteroids in humans with gram negative sepsis.
Schumer found that 30 mg/kg methylprednisolone givenl to patients "as soon as septic shock was clinically recognized" tripled survival (13) . In contrast, Thompson and associates (23) found no increase in survival in septic patients given the same dose of methylprednisolone 9 h after shock was recognized (23) . Detailed studies of the effects of steroids on survival in septic mice treated with antibiotics indicate that steroids have a beneficial effect only if given early in the course of sepsis (24) . If our data are relevant to gram negative sepsis in humans, they suggest that prevention of pulmonary complications requires that the drug be given very early in the septic course.
Sibbald and associates (25) , using clearance of intravenously injected radiolabeled albumin into airway secretions as a measure of "alveolo-capillary" permeability in humans with gram negative sepsis and respiratory failure, found that high doses of methylprednisolone given during periods of increased permeability would return permeability to normal (25) . Our data appear different. Once lung vascular permeability was increased after endotoxemia, methylprednisolone had no effect. There are two obvious possible explanations for the disparity. Since alveolar epithelium is less permeable than capillary endothelium (26) , epithelium is the primary barrier to movement of solutes from vascular space to airways. The data of Sibbald et al. (25) probably relate more to epithelial than endothelial permeability, whereas our data relate only to endothelial permeability. Corticosteroids could affect the two barriers differently. Perhaps more likely, humans may undergo repeated bouts of septicemia (and thus endotoxemia) so that giving steroids even after respiratory failure occurs may favorably affect responses to subsequent or concurrent endotoxemia.
Our data demonstrate that infusing E. coli endotoxin into unanesthetized sheep causes pulmonary hypertension initially, followed after several hours by a long period of increased lung vascular permeability. Large doses of methylprednisolone given before endotoxin largely prevent the response. Large doses of methylprednisolone begun during the early period of pulmonary hypertension largely prevent the later increase in permeability. Large doses of methylprednisolone given after permeability is increased do not reverse the abnormality. There are several possible explanations for the steroid effect. The clinical implications of our data may be that, given early in course of sepsis in humans, large doses of corticosteroids may help prevent the particularly devastating pulmonary complications of that disease.
